Jeeyun Lee MD
@JeeyunM
Followers
168
Following
333
Media
5
Statuses
59
Oncologist Samsung Medical Center
Republic of Korea
Joined May 2021
RT @KSMO_INTL: Stay Connected with #KSMO_INTL at #ASCO25 .We're excited to meet Korea–US oncologists at this special networking event!🥂 Let….
0
4
0
RT @ArndtVogel: Tremelimumab & durvalumab as neoadjuvant or non-operative management strategy for MSI GC/GEJ cancer.@Annals_Oncology .https….
0
10
0
RT @KlempnerSam: Adding some spatial omics to HER2+ gastric cancer. Determinants of Response to Sequential Pembrolizumab with Trastuzumab….
0
5
0
Claudin 18.2 and Fgfr2b in GC as first-line tx. Thanks to #weipengyong #hisatokaeakami, Dr. Kyoung Mee Kim #esmo2024 for insightful panel discussions. Exciting time to treat GI cancers with more tx options yet to come. #anminae
0
0
2
RT @HHorinouchi: 🔥#KSMO2024 #JSMO2025 booth.🙌We welcome 🇰🇷 and 🌎🌍participants to Kobe🇯🇵.🗓March 6th to 8th, 225.✔️English as Official langua….
0
8
0
RT @AnMinae: I’m deeply honored to receive this award (future leader award) for my postdoctoral work. https://t.….
0
1
0
Thank you for ASCO sessions especially @lynn_schuchter. @ASCO. We see stage iv everyday but still hard to judge when to start palliative care for each patient. @KSMO_INTL.
Enjoying Day 2 @ KSMO 2024, & today @lynn_schuchter co-chairs ASCO/KSMO Joint Symposium 7 w/ Dr. Kyung Hee Lee & speaks about integrating #palliativecare into onc care along w/ @tomleblancMD, @jungyong_hong. If you’re here at COEX, visit us @ the ASCO Booth in Hall 3F. @KSMO_INTL
1
1
19
RT @MyriamChalabi: @AndresC27622123 discussing neoadjuvant treatment of rectal cancers @KSMO_INTL @myESMO joint session in #Seoul. https://….
0
2
0
RT @LizzySmyth1: I'm excited to see this early data at #ESMO24 on AMG 193 for my patients with pancreas, biliary & oesophageal cancer 👏👏. M….
0
25
0
RT @ILSONDavid: Niche 2 after two doses of nivolumab and one dose of ipi and surgery. 100% of patients with MSI high colon cancer relapse f….
0
21
0
RT @CentralParkWMD: Extremely fortunate 💜to have the best mentor @EileenMOReilly and mentee @CatherineaOC A strong teamwork at @MSKCancerCe….
0
16
0
RT @ArndtVogel: Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 .🔎POCHI trial.👉ORR 74%, DRC 100%, 5 CR.👉….
0
51
0
RT @KoheiShitara: Pleased to share final survival results of two phase 3 of zolbetuximab @NEJM which reinforce zolbetuxumab plus chemo as….
0
61
0
RT @dr_yakupergun: #ESMO24 .T-DXd monotherapy and combinations in pts with advanced HER2+ esophageal, gastric or GEJ adenocarcinoma: DESTI….
0
8
0
RT @KSMO_INTL: 🌟Join us at KSMO Annual Meeting🌟.Stay connected with Korean oncologists at COEX, Seoul, Korea & online on September 26-27! H….
0
4
0
RT @CD_AACR: #OnlineFirst: Sequential #chemoimmunotherapy in #gastriccancer, by @AnMinae, @arnavmehta3, Byung Hoon Min, You Jeong Heo, Seun….
0
4
0
Congrats Martin. This is an excellent work. Hope we can use this test in the clinic someday. Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
0
0
4
RT @RonDePinho: Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker. Accurate, fast and cheap ($3) as….
0
22
0